Skip to main content

Table 2 Surgical-related characteristics

From: Effect of postoperative goal-directed therapy in cancer patients undergoing high-risk surgery: a randomized clinical trial and meta-analysis

Variable

GDHT group

(n = 64)

Usual care group

(n = 64)

Surgery type, n (%)

 Upper gastrointestinal tract

21 (33%)

13 (20%)

 Lower gastrointestinal tract

15 (23%)

14 (22%)

 Liver and biliary tract

2 (3%)

5 (8%)

 Urogenital tract

15 (23%)

22(34%)

 Others

11 (17%)

10 (16%)

Duration of surgery (min), median (IQR)

360 (273–480)

300 (240–435)

Fluids (ml), median (IQR)

4000 (3000–5763)

4000 (3000–5225)

Norepinephrine, n (%)

20 (31%)

19 (30%)

Dobutamine, n (%)

0

4 (6%)

Vasopressin, n (%)

1 (2%)

0

RBC transfusion, n (%)

19 (30%)

15 (23%)

Fresh frozen plasma, n (%)

2 (3%)

2 (3%)

Cryoprecipitate, n (%)

0

1 (2%)

Platelets, n (%)

1 (2%)

0

  1. GDHT goal directed hemodynamic therapy, IQR interquartile range, RBC red blood cell